Medicine and Dentistry
High Density Lipoprotein Cholesterol
100%
Patient
100%
Intervention Trial
66%
Risk Reduction
33%
Statin
33%
Pravastatin
33%
Inpatient
33%
Veterans Affairs
33%
Cardiovascular System
16%
Cholesterol
16%
Lipid
16%
Triacylglycerol
16%
Secondary Prevention
16%
Lifestyle
16%
Ischemia
16%
Combination Therapy
16%
Arteriosclerotic Heart Disease
16%
Hypertriglyceridemia
16%
Primary Prevention
16%
Bezafibrate
16%
Infarction
16%
Therapeutic Procedure
16%
Pharmacology, Toxicology and Pharmaceutical Science
High Density Lipoprotein Cholesterol
100%
Pravastatin
33%
Statin (Protein)
33%
Clinical Trial
33%
Lipid
16%
Triacylglycerol
16%
Cholesterol
16%
Ischemia
16%
Bezafibrate
16%
Infarction
16%
Coronary Artery Atherosclerosis
16%
Fibric Acid Derivative
16%